LIVE OAK MENTAL HEALTH AND WELLNESS
3445 Ingleside Blvd, Ladson, SC · HCA Trident Health System · · NPI 1124443478
Published prices by procedure
Cash price is what you pay without insurance. The negotiated range spans the lowest to highest rate this hospital agreed with insurers.
| Procedure | Cash price | Gross charge | Negotiated range | Payers |
|---|---|---|---|---|
| Inj, eteplirsen, 10 mg HCPCS J1428 | not published | not published | $173.23 – $254.78 | 5 |
| Inj, evinacumab-dgnb, 5mg HCPCS J1305 | not published | not published | $180.72 – $228.19 | 6 |
| Inj., evomela, 1 mg HCPCS J9246 | not published | not published | $17.95 – $45.58 | 6 |
| Inj, exagamglogene autotem HCPCS J3392 | not published | not published | $3,847,800.00 – $3,847,800.00 | 1 |
| Inj, factor x, (human), 1iu HCPCS J7175 | not published | not published | $8.39 – $16.37 | 5 |
| Inj, faricimab-svoa, 0.1mg HCPCS J2777 | not published | not published | $33.68 – $49.85 | 6 |
| Inj fe-based mr contrast,1ml HCPCS Q9953 | not published | not published | $79.84 – $79.84 | 2 |
| Inj. fe derisomaltose 10 mg HCPCS J1437 | not published | not published | $20.21 – $31.29 | 6 |
| Inj fensolvi 0.25 mg HCPCS J1951 | not published | not published | $130.23 – $182.77 | 6 |
| Inj ferric pyrophosphate cit HCPCS J1443 | not published | not published | $0.04 – $0.04 | 2 |
| Inj., fibryga, 1 mg HCPCS J7177 | not published | not published | $1.07 – $2.22 | 6 |
| Inj fluphenazine hcl 1.25 mg HCPCS J2679 | not published | not published | $6.94 – $12.19 | 2 |
| Inj, focinvez, 1mg HCPCS J1434 | not published | not published | $2.93 – $4.34 | 5 |
| Inj for ext venography CPT 36005 | not published | not published | $364.13 – $364.13 | 2 |
| Inj, fosaprepitant (teva) HCPCS J1456 | not published | not published | $1.06 – $1.17 | 2 |
| Inj fosnetupitant, palonoset HCPCS J1454 | not published | not published | $435.91 – $782.05 | 6 |
| Inj., fremanezumab-vfrm 1 mg HCPCS J3031 | not published | not published | $3.08 – $3.78 | 4 |
| Inj, fulvestrant (fresenius) HCPCS J9394 | not published | not published | $2.05 – $53.72 | 6 |
| Inj, fulvestrant (teva) HCPCS J9393 | not published | not published | $21.49 – $26.29 | 5 |
| Inj, gadopiclenol, 1 ml HCPCS A9573 | not published | not published | $3.37 – $13.48 | 3 |
| Inj, ganciclovir (exela) HCPCS J1574 | not published | not published | $61.01 – $61.01 | 2 |
| Inj gemcitabine hcl (accord) HCPCS J9196 | not published | not published | $4.61 – $8.39 | 3 |
| Inj givosiran 0.5 mg HCPCS J0223 | not published | not published | $112.98 – $155.08 | 6 |
| Inj glofitamab gxbm, 2.5 mg HCPCS J9286 | not published | not published | $2,664.57 – $4,691.92 | 5 |
| Inj glycopyrrolate fres kabi HCPCS J1598 | not published | not published | $1.61 – $2.21 | 2 |
| Inj glycopyrrolate, glyrx-pf HCPCS J1597 | not published | not published | $2.11 – $2.11 | 1 |
| Inj golodirsen 10 mg HCPCS J1429 | not published | not published | $200.38 – $200.38 | 2 |
| Inj, granisetron, xr, 0.1 mg HCPCS J1627 | not published | not published | $5.13 – $7.60 | 6 |
| Inj., guselkumab, 1 mg HCPCS J1628 | not published | not published | $68.32 – $161.21 | 6 |
| Inj., haegarda 10 units HCPCS J0599 | not published | not published | $10.71 – $14.40 | 5 |
| Inj, hemgenix, per tx dose HCPCS J1411 | not published | not published | $6,080,690.01 – $6,080,690.01 | 1 |
| Inj heparin, pfizer, 1000u HCPCS J1643 | not published | not published | $2.85 – $7.55 | 3 |
| Inj. herceptin hylecta, 10mg HCPCS J9356 | not published | not published | $61.03 – $112.99 | 6 |
| Inj, hercessi, 10 mg HCPCS Q5146 | not published | not published | $61.30 – $109.20 | 4 |
| Inj herzuma 10 mg HCPCS Q5113 | not published | not published | $40.63 – $71.69 | 3 |
| Inj hrt cath w/s&i nonsel p-art angrp CPT 93568 | not published | not published | $3,641.31 – $3,641.31 | 2 |
| Inj hrt cath w/s&i sel hrt ang CPT 93563 | not published | not published | $3,641.31 – $3,641.31 | 2 |
| Inj hrt cath w/s&i sel hrt art CPT 93564 | not published | not published | $3,641.31 – $3,641.31 | 2 |
| Inj hrt cath w/s&i sel left vent CPT 93565 | not published | not published | $3,641.31 – $3,641.31 | 2 |
| Inj hrt cath w/s&i sel right vent CPT 93566 | not published | not published | $3,641.31 – $3,641.31 | 2 |
| Inj human fibrinogen con nos HCPCS J7178 | not published | not published | $0.89 – $2.52 | 5 |
| Inj hydroxocobalamin IV 25mg HCPCS J3424 | not published | not published | $4.38 – $8.98 | 4 |
| Inj hydroxyprogst capoat nos HCPCS J1729 | not published | not published | $18.80 – $18.80 | 2 |
| Inj., ibalizumab-uiyk, 10 mg HCPCS J1746 | not published | not published | $68.07 – $127.94 | 5 |
| Inj, idacio, 1 mg HCPCS Q5144 | not published | not published | $23.95 – $29.29 | 3 |
| Inj imip 4 cilas 4 releb 2mg HCPCS J0742 | not published | not published | $2.42 – $3.32 | 6 |
| Inj, imm glob bivigam, 500mg HCPCS J1556 | not published | not published | $52.08 – $74.98 | 5 |
| Inj, immphentiv, 20 mcg HCPCS J2373 | not published | not published | $0.14 – $0.23 | 2 |
| Inj. inebilizumab-cdon, 1 mg HCPCS J1823 | not published | not published | $469.87 – $635.83 | 6 |
| Inj/inf neurolyt sbst spinal canal lesion 62282 CPT 62282 | not published | not published | $1,019.57 – $1,560.13 | 5 |
| Inj. infugem, 100 mg HCPCS J9198 | not published | not published | $51.83 – $51.83 | 2 |
| Inj. insulin (fiasp) HCPCS J1812 | not published | not published | $1.12 – $1.77 | 2 |
| Inj intralesional <= 7 lsn(s) CPT 11900 | not published | not published | $163.84 – $1,019.57 | 5 |
| Inj intralesional > 7 lsns CPT 11901 | not published | not published | $163.84 – $1,019.57 | 5 |
| Inj, invega hafyera/trinza HCPCS J2427 | not published | not published | $12.29 – $16.62 | 6 |
| Inj ivig privigen 500 mg HCPCS J1459 | not published | not published | $47.70 – $123.88 | 6 |
| Inj, ixinity, 1 i.u HCPCS J7213 | not published | not published | $1.86 – $2.22 | 6 |
| Inj. jivi 1 iu HCPCS J7208 | not published | not published | $2.38 – $4.37 | 5 |
| Inj, kovaltry, 1 i.u HCPCS J7211 | not published | not published | $1.45 – $2.59 | 5 |
| Inj labetalol hcl hikma, 5mg HCPCS J1921 | not published | not published | $1.34 – $1.80 | 2 |
| Inj., lanadelumab-flyo, 1 mg HCPCS J0593 | not published | not published | $82.26 – $110.77 | 6 |
| Inj, lanreotide, (cipla) 1mg HCPCS J1932 | not published | not published | $24.66 – $83.81 | 6 |
| Inj, lecanemab-irmb, 1 mg HCPCS J0174 | not published | not published | $1.29 – $1.55 | 3 |
| Inj lefamulin 1 mg HCPCS J0691 | not published | not published | $0.83 – $0.93 | 4 |
| Inj, lenacapavir, 1 mg HCPCS J1961 | not published | not published | $21.37 – $28.80 | 6 |
| Inj levocarnitine per 1 gm HCPCS J1955 | not published | not published | $8.94 – $45.57 | 6 |
| Inj levoleucovorin nos 0.5mg HCPCS J0641 | not published | not published | $0.02 – $1.72 | 5 |
| Inj, levothyroxine, freskabi HCPCS J0651 | not published | not published | $6.21 – $11.45 | 5 |
| Inj, levothyroxine, hikma HCPCS J0652 | not published | not published | $4.99 – $12.69 | 5 |
| Inj, lidocaine w epinephrine HCPCS J2004 | not published | not published | $0.07 – $0.07 | 1 |
| Inj, linezolid (hospira) HCPCS J2021 | not published | not published | $6.15 – $11.76 | 3 |
| Inj, lovotibeglogene autotem HCPCS J3394 | not published | not published | $5,366,638.33 – $5,366,638.33 | 1 |
| Inj. lumasiran, 0.5 mg HCPCS J0224 | not published | not published | $309.28 – $424.26 | 6 |
| Inj., lumoxiti, 0.01 mg HCPCS J9313 | not published | not published | $24.99 – $32.12 | 5 |
| Inj luxturna 1 billion vec g HCPCS J3398 | not published | not published | $3,399.02 – $4,343.37 | 5 |
| Inj marstacim-hncq, 0.5 mg HCPCS J7172 | not published | not published | $52.02 – $83.28 | 4 |
| Inj. meloxicam 1 mg HCPCS J1738 | not published | not published | $3.76 – $4.12 | 4 |
| Inj melpha hydroch nos 50 mg HCPCS J9245 | not published | not published | $143.45 – $1,483.80 | 6 |
| Inj, melphalan (apotex) 1 mg HCPCS J9249 | not published | not published | $106.89 – $106.89 | 1 |
| Inj, melphalan flufenami 1mg HCPCS J9247 | not published | not published | $604.20 – $604.20 | 2 |
| Inj melphalan (hepzato) 1 mg HCPCS J9248 | not published | not published | $739.20 – $1,311.75 | 5 |
| Inj mepivacaine hcl/10 ml HCPCS J0670 | not published | not published | $3.52 – $3.96 | 3 |
| Inj, meropenem (b. braun) HCPCS J2184 | not published | not published | $2.03 – $2.60 | 3 |
| Inj., meropenem, vaborbactam HCPCS J2186 | not published | not published | $1.97 – $3.60 | 4 |
| Inj meropenem (wg crit care) HCPCS J2183 | not published | not published | $1.55 – $2.59 | 2 |
| Inj, micafungin (par pharm) HCPCS J2247 | not published | not published | $0.30 – $0.36 | 3 |
| Inj, mirikizumab-mrkz, 1 mg HCPCS J2267 | not published | not published | $27.27 – $69.17 | 5 |
| Inj mogamulizumab-kpkc, 1 mg HCPCS J9204 | not published | not published | $215.97 – $275.82 | 6 |
| Inj, motixafortide, 0.25 mg HCPCS J2277 | not published | not published | $24.46 – $43.69 | 5 |
| Inj, moxifloxacin 100 mg HCPCS J2280 | not published | not published | $8.31 – $12.67 | 3 |
| Inj moxifloxacin (fres kabi) HCPCS J2281 | not published | not published | $5.58 – $6.89 | 3 |
| Inj multihance HCPCS A9577 | not published | not published | $1.77 – $2.97 | 2 |
| Inj multihance multipack HCPCS A9578 | not published | not published | $1.76 – $2.90 | 2 |
| Inj. mycophenolate mofetil HCPCS J7519 | not published | not published | $0.30 – $0.91 | 4 |
| Inj naloxone hydrochloride HCPCS J2310 | not published | not published | $8.93 – $12.16 | 3 |
| Inj. naxitamab-gqgk, 1 mg HCPCS J9348 | not published | not published | $560.70 – $718.77 | 6 |
| Inj, nithiodote, 3mg / 125mg HCPCS J0211 | not published | not published | $2.02 – $3.58 | 4 |
| Inj nivolumab 2 mg hyaluron HCPCS J9289 | not published | not published | $25.14 – $45.87 | 4 |
| Inj, nogapendekin pmln, 1mcg HCPCS J9028 | not published | not published | $90.63 – $156.30 | 5 |
| Inj non-compmd foam sclrsnt mlt trncl veins same leg CPT 36466 | not published | not published | $2,202.95 – $2,202.95 | 1 |
A missing value means the hospital did not publish that price — it never means the price is zero. Real bills can add facility fees, supplies and professional fees; see our methodology.